These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24283437)

  • 1. Quantitative structure and bioactivity relationship study on HCV NS5B polymerase inhibitors.
    Wang M; Zhong M; Yan A; Li L; Yu C
    SAR QSAR Environ Res; 2014; 25(1):1-15. PubMed ID: 24283437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of HCV NS5B polymerase inhibitors using support vector machine.
    Wang M; Wang K; Yan A; Yu C
    Int J Mol Sci; 2012; 13(4):4033-4047. PubMed ID: 22605964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM).
    Qin Z; Wang M; Yan A
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2931-2938. PubMed ID: 28501513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    Mol Divers; 2011 Aug; 15(3):645-53. PubMed ID: 20931278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.
    Musmuca I; Caroli A; Mai A; Kaushik-Basu N; Arora P; Ragno R
    J Chem Inf Model; 2010 Apr; 50(4):662-76. PubMed ID: 20225870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification models of HCV NS3 protease inhibitors based on support vector machine (SVM).
    Wang M; Xuan S; Yan A; Yu C
    Comb Chem High Throughput Screen; 2015; 18(1):24-32. PubMed ID: 25410306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Patel PD; Patel MR; Kaushik-Basu N; Talele TT
    J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
    Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
    Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors.
    Worachartcheewan A; Prachayasittikul V; Toropova AP; Toropov AA; Nantasenamat C
    Mol Divers; 2015 Nov; 19(4):955-64. PubMed ID: 26164590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined 3D-QSAR, molecular docking, molecular dynamics simulation, and binding free energy calculation studies on the 5-hydroxy-2H-pyridazin-3-one derivatives as HCV NS5B polymerase inhibitors.
    Yu H; Fang Y; Lu X; Liu Y; Zhang H
    Chem Biol Drug Des; 2014 Jan; 83(1):89-105. PubMed ID: 23941500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of bioactivity of ACAT2 inhibitors by multilinear regression analysis and support vector machine.
    Zhong M; Xuan S; Wang L; Hou X; Wang M; Yan A; Dai B
    Bioorg Med Chem Lett; 2013 Jul; 23(13):3788-92. PubMed ID: 23711921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
    J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative structure and bioactivity relationship study on human acetylcholinesterase inhibitors.
    Yan A; Wang K
    Bioorg Med Chem Lett; 2012 May; 22(9):3336-42. PubMed ID: 22460031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminating of ATP competitive Src kinase inhibitors and decoys using self-organizing map and support vector machine.
    Yan A; Hu X; Wang K; Sun J
    Mol Divers; 2013 Feb; 17(1):75-83. PubMed ID: 23117252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational models on quantitative prediction of bioactivity of HIV-1 integrase 3' processing inhibitors.
    Kong Y; Xuan S; Yan A
    SAR QSAR Environ Res; 2014; 25(9):729-46. PubMed ID: 25121566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
    Cao H; Cao R; Zhang H; Zheng X; Gao D
    Curr Med Chem; 2008; 15(15):1462-77. PubMed ID: 18537623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatitis-C virus activity and QSAR study of certain thiazolidinone and thiazolotriazine derivatives as potential NS5B polymerase inhibitors.
    Hassan GS; Georgey HH; Mohammed EZ; Omar FA
    Eur J Med Chem; 2019 Dec; 184():111747. PubMed ID: 31604164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors.
    May MM; Brohm D; Harrenga A; Marquardt T; Riedl B; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Antiviral Res; 2012 Aug; 95(2):182-91. PubMed ID: 22580131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study.
    Elfiky AA
    Med Chem; 2019; 15(2):130-137. PubMed ID: 30324891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Organizing Map (SOM) and Support Vector Machine (SVM) Models for the Prediction of Human Epidermal Growth Factor Receptor (EGFR/ ErbB-1) Inhibitors.
    Kong Y; Qu D; Chen X; Gong YN; Yan A
    Comb Chem High Throughput Screen; 2016; 19(5):400-11. PubMed ID: 27074760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.